• Etude concernée: IFCT-1601
  • Auteurs / Authors: M. Wislez, J. Mazieres, A. Lavole, G. Zalcman, O. Carre, T. Egenod, R. Caliandro, R. Gervais, G. Jeannin, O. Molinier, M.A. Massiani, A. Langlais, F. Morin, F. Le Pimpec Barthes, L. Brouchet, J. Assouad, B. Milleron, D. Damotte, M. Antoine, V. Westeel
  • Journal / Conference: ESMO
  • Année / Year: 2020
  • PMID: Oral abstract
  • Lien vers la publication: https://oncologypro.esmo.org/meeting-resources/esmo-virtual-congress-2020/neoadjuvant-durvalumab-in-resectable-non-small-cell-lung-cancer-nsclc-preliminary-results-from-a-multicenter-study-ifct-1601-ionesco